An FDA advisory panel recommends 1-year pre-market study and 5-year post-market surveillance for flow diverters used to treat brain aneurysms.
An FDA panel last week issued its recommendations for pre- and post-market studies of flow diverters used to treat brain aneurysms.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1EopCh2
Cap comentari:
Publica un comentari a l'entrada